Fundz

Atea Pharmaceuticals Secures Up to $200 Million in Loan Financing

PUBLIC · AVIRNov 09, 2026

Amount Raised

$200 Million

Round Type

Debt Financing

BostonBiotechnology

Investors

Hercules Capital, Inc.

Description

On November 6, 2026, Atea Pharmaceuticals, Inc. entered into a Loan and Security Agreement providing for term loans totaling up to $200 million. The initial draw of $65 million is aimed to support the development of its antiviral therapy. Additional tranches are contingent on specific milestones related to ongoing clinical trials

Who else raised in Biotechnology around the same time

Companies in the same sectors as Atea Pharmaceuticals, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Helios raised $2.3M (Seed) on November 21, 2026.
  • DawaDose raised an undisclosed amount (Seed) on November 19, 2026.
  • Xellar Biosystems raised an undisclosed amount on November 19, 2026.
  • MetaIntelli Tech raised $45M (Pre-Series A) on November 19, 2026.
  • MegaRobo raised $200M on November 19, 2026.
  • Vitri Vax raised $87M (Series C) on November 18, 2026.

Who to call at Atea Pharmaceuticals, Inc., and when

A new round usually means Atea Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Atea Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Atea Pharmaceuticals, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Atea Pharmaceuticals, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Atea Pharmaceuticals, Inc.

Location

125 SUMMER ST.

Boston, Massachusetts, United States

About

A pharmaceutical company based in boston.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Atea Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Atea Pharmaceuticals, Inc.'s next move

See what Strategic adds

Atea Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.